跳转至内容
Merck
CN

T6817

Monoclonal Anti-Tumor Necrosis Factor-α antibody produced in mouse

clone 28401, purified immunoglobulin, lyophilized powder

别名:

Anti-TNF-α

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
12352203
NACRES:
NA.41
MDL number:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

Monoclonal Anti-Tumor Necrosis Factor-α antibody produced in mouse, clone 28401, purified immunoglobulin, lyophilized powder

biological source

mouse

conjugate

unconjugated

antibody form

purified immunoglobulin

antibody product type

primary antibodies

clone

28401, monoclonal

form

lyophilized powder

species reactivity

human

technique(s)

capture ELISA: 4 μg/mL
immunocytochemistry: 8-25 μg/mL using Immersion fixed human peripheral blood mononuclear cells (PBMSs) stimulated with LPS and monensin.
neutralization: suitable
western blot: 1.0-2.0 μg/mL

impurities

<0.10 EU/μg

isotype

IgG1

UniProt accession no.

storage temp.

−20°C

target post-translational modification

unmodified

Quality Level

Gene Information

human ... TNF(7124)

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Immunogen

recombinant human TNF-α, expressed in E. coli

Physical form

Lyophilized from a 0.2 μm filtered solution in phosphate buffered saline containing 5% trehalose.

Preparation Note

Purified using protein G

未找到合适的产品?  

试试我们的产品选型工具.

存储类别

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)

法规信息

常规特殊物品
此项目有

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Meline Nogueira Lucena Stölting et al.
The Journal of urology, 189(5), 1952-1959 (2012-11-06)
Myoblasts can form muscle fibers after transplantation. Therefore, they are envisioned as a treatment for urinary incontinence after radical prostatectomy. However, to our knowledge the safety of this treatment and the interaction of myoblasts with any remaining neighboring cancer are

相关内容

Instructions

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持